menu search

AUTL / Autolus Therapeutics plc (AUTL) Q3 2023 Earnings Call Transcript

Autolus Therapeutics plc (AUTL) Q3 2023 Earnings Call Transcript
Autolus Therapeutics plc (NASDAQ:AUTL ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Julia Wilson – Investor Relations Christian Itin – Chief Executive Officer Rob Dolski – Chief Financial Officer Conference Call Participants Matthew Phipps – William Blair Dev Prasad – Jefferies Gil Blum – Needham and Company Yanan Zhu – Wells Fargo Karina Rabayeva – Truist Simon Baker – Redburn Atlantic Operator Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Third Quarter 2023 Financial Results Conference Call and Business Update. At this time, all participants are in listen-only mode. Read More
Posted: Nov 3 2023, 22:05
Author Name: Seeking Alpha
Views: 022812

AUTL News  

Autolus Therapeutics plc (AUTL) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 3, 2023

Autolus Therapeutics plc (AUTL) Q3 2023 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Julia Wilson – Investor Re more_horizontal

Correction - Autolus Therapeutics to report third quarter 2023 financial results and host conference call on November 2, 2023

By GlobeNewsWire
October 11, 2023

Correction - Autolus Therapeutics to report third quarter 2023 financial results and host conference call on November 2, 2023

LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generat more_horizontal

Autolus Therapeutics plc (AUTL) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 6, 2023

Autolus Therapeutics plc (AUTL) Q2 2023 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Dr. Christian Itin - CEO Dr. L more_horizontal

Autolus Therapeutics Could Hold A Winning CAR T-Cell Ticket

By Seeking Alpha
June 30, 2023

Autolus Therapeutics Could Hold A Winning CAR T-Cell Ticket

Obe-cel and pipeline offer many catalysts in 2023. The CAR T-cell candidate offer a safer alternative to commercial rivals. Strong cash position shoul more_horizontal

3 Top Penny Stock Picks You Haven't Heard Of

By InvestorPlace
June 14, 2023

3 Top Penny Stock Picks You Haven't Heard Of

Unless you regularly invest in or research penny stocks it's likely you aren't familiar with most companies in the space. These penny stock picks are more_horizontal

Autolus Therapeutics (AUTL) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 7, 2023

Autolus Therapeutics (AUTL) Q4 2022 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL ) Q4 2022 Earnings Conference Call March 7, 2023 8:30 AM ET Company Participants Christian Itin - Chief Executiv more_horizontal

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022

By GlobeNewsWire
December 12, 2022

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022

LONDON, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generat more_horizontal

Why Autolus Therapeutics Stock Is Crashing Today

By The Motley Fool
December 9, 2022

Why Autolus Therapeutics Stock Is Crashing Today

The biopharmaceutical company announced the pricing of a secondary stock offering. more_horizontal


Search within

Pages Search Results: